2788 Stock Overview
Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Luyan Pharma Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.28 |
| 52 Week High | CN¥10.38 |
| 52 Week Low | CN¥6.10 |
| Beta | 0.41 |
| 1 Month Change | 1.35% |
| 3 Month Change | 0.73% |
| 1 Year Change | -10.20% |
| 3 Year Change | 7.25% |
| 5 Year Change | -19.61% |
| Change since IPO | -21.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2788 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 1.5% | -0.3% | -0.2% |
| 1Y | -10.2% | -34.7% | -17.8% |
Return vs Industry: 002788 exceeded the CN Healthcare industry which returned -34.7% over the past year.
Return vs Market: 002788 exceeded the CN Market which returned -17.8% over the past year.
Price Volatility
| 2788 volatility | |
|---|---|
| 2788 Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 002788 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002788's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 5,286 | Jinxiang Wu | www.luyan.com.cn |
Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores.
Luyan Pharma Co.,Ltd. Fundamentals Summary
| 2788 fundamental statistics | |
|---|---|
| Market cap | CN¥3.26b |
| Earnings (TTM) | CN¥363.53m |
| Revenue (TTM) | CN¥19.85b |
8.8x
P/E Ratio0.2x
P/S RatioIs 2788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2788 income statement (TTM) | |
|---|---|
| Revenue | CN¥19.85b |
| Cost of Revenue | CN¥18.34b |
| Gross Profit | CN¥1.51b |
| Other Expenses | CN¥1.15b |
| Earnings | CN¥363.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.94 |
| Gross Margin | 7.60% |
| Net Profit Margin | 1.83% |
| Debt/Equity Ratio | 180.5% |
How did 2788 perform over the long term?
See historical performance and comparison